Literature DB >> 9917000

Mouse models in tumor suppression.

N Ghebranious1, L A Donehower.   

Abstract

Genetic lesions found in tumors are often targeted to the negative growth regulatory tumor suppressor genes. Much of our understanding of tumor suppressor gene function is derived from experimental manipulations in cultured cells. Recently, however, the generation of mice with germ line tumor suppressor gene mutations through gene targeting in embryonic stem cells has provided another dimension by allowing experimental studies of tumor suppressor function in an organismal context. Novel insights into the role of tumor suppressors in development, differentiation, cell cycle control, and tumor suppression have been obtained from the studies on these 'knockout' mice. In addition, such mice may serve as disease models for humans with inherited cancer predisposition syndromes. Perhaps the greatest advantage of many of the mouse tumor suppressor models is that they facilitate study of the roles of tumor suppressor gene loss in tumor initiation and progression in vivo. Moreover, derivation of primary cells from tumor suppressor-deficient mice has provided an important resource for in vitro studies on the role of targeted genes in cell cycle regulation, DNA damage response, regulation of apoptotic pathways, and preservation of genomic stability. In this review, we discuss some of the mechanistic insights provided by tumor suppressor-deficient mice and their utility as models for human cancer syndromes.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9917000     DOI: 10.1038/sj.onc.1202573

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  17 in total

1.  New mouse models of cancer: single-cell knockouts.

Authors:  Guillermina Lozano; Richard R Behringer
Journal:  Proc Natl Acad Sci U S A       Date:  2007-03-05       Impact factor: 11.205

Review 2.  NF-kappaB pathways in the immune system: control of the germinal center reaction.

Authors:  Christine A Goetz; Albert S Baldwin
Journal:  Immunol Res       Date:  2008       Impact factor: 2.829

3.  Ablation of NF1 function in neurons induces abnormal development of cerebral cortex and reactive gliosis in the brain.

Authors:  Y Zhu; M I Romero; P Ghosh; Z Ye; P Charnay; E J Rushing; J D Marth; L F Parada
Journal:  Genes Dev       Date:  2001-04-01       Impact factor: 11.361

4.  Loss of transcription factor IRF-1 affects tumor susceptibility in mice carrying the Ha-ras transgene or nullizygosity for p53.

Authors:  H Nozawa; E Oda; K Nakao; M Ishihara; S Ueda; T Yokochi; K Ogasawara; Y Nakatsuru; S Shimizu; Y Ohira; K Hioki; S Aizawa; T Ishikawa; M Katsuki; T Muto; T Taniguchi; N Tanaka
Journal:  Genes Dev       Date:  1999-05-15       Impact factor: 11.361

Review 5.  PTEN, the Achilles' heel of myocardial ischaemia/reperfusion injury?

Authors:  M M Mocanu; D M Yellon
Journal:  Br J Pharmacol       Date:  2007-02-12       Impact factor: 8.739

6.  BMP4-Smad signaling pathway mediates adriamycin-induced premature senescence in lung cancer cells.

Authors:  Dongmei Su; Shan Zhu; Xuefang Han; Yunpeng Feng; Hui Huang; Guoling Ren; Lina Pan; Yu Zhang; Jun Lu; Baiqu Huang
Journal:  J Biol Chem       Date:  2009-03-06       Impact factor: 5.157

7.  Molecular biology of gynecological cancer.

Authors:  Kenzo Sonoda
Journal:  Oncol Lett       Date:  2015-11-05       Impact factor: 2.967

8.  Necdin, a p53-target gene, is an inhibitor of p53-mediated growth arrest.

Authors:  Julie Lafontaine; Francis Rodier; Véronique Ouellet; Anne-Marie Mes-Masson
Journal:  PLoS One       Date:  2012-02-15       Impact factor: 3.240

9.  Autophagy in premature senescent cells is activated via AMPK pathway.

Authors:  Liujing Guo; Bushan Xie; Zebin Mao
Journal:  Int J Mol Sci       Date:  2012-03-16       Impact factor: 6.208

Review 10.  Biology of urothelial tumorigenesis: insights from genetically engineered mice.

Authors:  Xue-Ru Wu
Journal:  Cancer Metastasis Rev       Date:  2009-12       Impact factor: 9.264

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.